Initial Metabolic Changes (Days 1-14): While cellular-level metabolic changes begin within hours of the first AOD-9604 administration, noticeable subjective effects typically emerge within the first one to two weeks
The glutathione system of Aspergillus nidulans involves a fungus-specific glutathione [PMID: 19171936] Laboratory literature summary: The glutathione system of Aspergillus nidulans involves a fungus-specific glutathione S-transferase
[33, 34, 35, 36] Mechanism: Typically pre-renal, occurring in the setting of volume depletion from GI losses (nausea, vomiting, diarrhea, reduced oral intake) More frequently seen at higher, obesity-level doses Although generally reno-protective long term, post-marketing data describe acute rises in creatinine following days to weeks of significant GI symptoms Risk factors: Underlying chronic kidney disease Concomitant use of ACE inhibitors, ARBs, diuretics, or SGLT2 inhibitors ED Management: IV fluids Hold GLP-1 and contributing medications Usually reversible with supportive care Future Directions GLP-1 receptor agonists are rapidly evolving beyond their original indications in diabetes and obesity
This framing is uncomfortable for many people who view medication as something you take temporarily until a problem resolves, but it aligns with the biological reality of obesity as a chronic disease with chronic neurohormonal underpinnings
Patients who titrate slowly (4-week intervals between dose increases) generate less acute oxidative stress than those who escalate every 2 weeks
However, you want to do a lot of prep work if theyre ever planning on going off of them, because especially a person whos kind of frantic at the idea of that food noise, of those cravings, thinking somethings wrong with them, if they get them when you go off, thats going to be, I dunno, two to four times more intense than prior to even going on them